Kathirvel Subramaniam
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Kathirvel Subramaniam sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).
Kathirvel Subramaniam: 5 sponsored US clinical trials, none currently recruiting.
Kathirvel Subramaniam sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Valve Regurgitation, Tricuspid, with 1 trials.
Upper-quartile sponsor footprint
Kathirvel Subramaniam sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
5 total, page 1 of 1
Precision Analgesia for Cardiac Surgery
NCT05612399
Comparison of Sternal Wound Infiltration With Liposomal Bupivacaine v. Bupivacaine Hydrochloride
NCT03270514
Inhaled Anesthetics and Myocardial Strain
NCT03569085
IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) Population
NCT03198871
Remifentanil and Glycemic Response in Cardiac Surgery
NCT02349152
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
How the Kathirvel Subramaniam archive is shaped
5 indexed studies, none listed as recruiting (0% open); 4 completed (80%).
Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).
Top condition: Valve Regurgitation, Tricuspid (1 trial), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Kathirvel Subramaniam: archived-pipeline peers nationwide
Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Kathirvel Subramaniam sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 5 archived trials
- 4YouandMe · 5 trials · 0% recruiting
- Abbott Rapid Dx · 5 trials · 0% recruiting
- Access Business Group · 5 trials · 0% recruiting
- Acera Surgical · 5 trials · 20% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Kathirvel Subramaniam page
5 registered trials is a research-attention snapshot, not an endorsement of Kathirvel Subramaniam or any single study.
- None of Kathirvel Subramaniam's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Valve Regurgitation, Tricuspid is the condition Kathirvel Subramaniam studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Valve Regurgitation, Tricuspid trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Kathirvel Subramaniam pipeline card: 5 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.